ВІСТАЗОЛ

उत्पाद अवलोकन

About ВІСТАЗОЛ

ВІСТАЗОЛ is a medication containing the active ingredient Zoledronic acid, a bisphosphonate used in the treatment of various bone-related disorders. It is administered intravenously to help manage bone resorption and prevent skeletal fractures in patients with conditions such as osteoporosis, bone metastases, and multiple myeloma.

Key Benefits & Uses

• Treatment of osteoporosis in postmenopausal women and men to reduce the risk of vertebral and non-vertebral fractures.
• Prevention of skeletal fractures in patients with bone metastases from solid tumors.
• Treatment of bone lesions in patients with multiple myeloma and other malignancies.

Active Ingredient & Action

Zoledronic acid works by inhibiting osteoclast-mediated bone resorption, thereby reducing bone turnover and increasing bone density. It binds to hydroxyapatite in bone, making it resistant to bone resorption and helping to maintain bone strength.

Important Notes

ВІСТАЗОЛ should be administered under the guidance of a healthcare professional. Patients with certain kidney problems or those taking other medications that affect kidney function should be closely monitored. Common side effects include hypocalcemia, fatigue, and flu-like symptoms. It is essential to follow the recommended dosing schedule and consult a doctor if any adverse reactions occur.